| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.9B | $14.9B | $15.1B | $13.0B | $8.7B | $1.8B | $2.2B | $2.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | $0.5B | $0.5B | $0.4B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.5B | $0.5B | $0.4B | $0.3B | $0.3B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $14.72 | $13.51 | $11.99 | $9.14 | $8.44 | $1.68 | $0.69 | $0.52 |
| EPS (Diluted) | $14.64 | $13.43 | $11.91 | $9.10 | $8.38 | $1.67 | $0.68 | $0.51 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.2B | $6.3B | $5.9B | $5.5B | $4.5B | $3.9B | $3.7B | $3.5B |
| Current Assets | $1.0B | $0.8B | $0.9B | $0.7B | $0.7B | $0.4B | $0.4B | $0.4B |
| Cash & Equivalents | $0.3B | $0.2B | $0.4B | $0.2B | $0.3B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $4.7B | $3.3B | $3.3B | $3.3B | $2.5B | $2.3B | $2.3B | $2.2B |
| Current Liabilities | $1.1B | $1.0B | $0.9B | $0.9B | $0.6B | $1.1B | $0.6B | $0.5B |
| Stockholders' Equity | $3.5B | $3.0B | $2.7B | $2.2B | $1.9B | $1.6B | $1.4B | $1.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $0.9B | $0.9B | $0.8B | $0.8B | $0.5B | $0.5B | $0.4B |
| Investing Cash Flow | $-1.7B | $-0.8B | $-0.5B | $-1.2B | $-0.4B | $-0.5B | $-0.5B | $-0.6B |
| Capital Expenditures | $0.5B | $0.5B | $0.5B | $0.3B | $0.4B | $0.4B | $0.4B | $0.6B |
| Financing Cash Flow | $0.8B | $-0.2B | $-0.1B | $0.2B | $-0.1B | $-0.0B | $-0.1B | $0.2B |